This is a preview of subscription content, log in via an institution to check access.
Reference
Sirrs SM, et al. Independent Registries Are Cost-Effective Tools to Provide Mandatory Postauthorization Surveillance for Orphan Medicinal Products. Value in Health : 19 Nov 2020. Available from: URL: https://doi.org/10.1016/j.jval.2020.10.006
Rights and permissions
About this article
Cite this article
Independent registries cost effective for postauthorisation surveillance. PharmacoEcon Outcomes News 867, 20 (2020). https://doi.org/10.1007/s40274-020-7317-0
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40274-020-7317-0